Göncz, E., Grötzinger, C., Mergler, S., El-Zayat, B. F., Theodoropoulou, M., Stalla, G. K., Wiedenmann, B., Plöckinger, U., & Strowski, M. Z. (2007). EGR-1 and CREB are target molecules for orexin-A dependent inhibition of glucagon gene expression. Experimental and Clinical Endocrinology & Diabetes, 115(Suppl. 1), S32-S32.